Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment succeeded in a pair of midstage studies. The post Novartis Just Cruised Past A Buy Point Amid Its Roche, Sanofi Rivalry appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real